. 2022 Dec 30;34(6):601–611. doi: 10.21147/j.issn.1000-9604.2022.06.08

Table 3. Geometric mean and ratio of PK parameters of ripertamab and rituximab.

Parameters	Geometric mean and ratio			90% CI
Parameters	Ripertamab (n=38)	Rituximab* (n=38)	ratio^† (%)	90% CI
PK, pharmacokinetics; AUC, area under the concentration-time curve; AUC_{0−85 d}, AUC from time 0 to d 85; AUC_0−inf, AUC from time 0 to infinity; C_max, maximum serum concentration; 90% CI, 90% confidence interval. ^†, Ratio refers to geometric means of PK parameters of ripertamab/rituximab; *, rituximab refers to MabThera^®.
AUC_{0−85 d}	63,448.164	66,020.898	96.1	87.6−105.5
AUC_0−inf	67,304.617	70,190.499	95.9	86.5−106.4
C_max	217.891	223.701	97.4	91.6−103.6